• 54,873+ CME Conference Registrations Sold
  • 164,620+ Medical Conferences
  • 297 Specialties
  • 11,711 Organizers
  • 159,490 Speakers
  • 159 Countries
  • 4,848 Cities
Duration: CME/CE Points: Author(s):
CME : 0.75

Neurology: High-Dose Immunosuppressive Therapy and Autologous Hematopoietic Cell Transplantation (HCT) for Relapsing-Remitting Multiple sclerosis (MS) is organized by American Academy of Neurology (AAN) and will be held during Feb 28, 2017 - Feb 28, 2020.

The target audience for this medical event is physicians who are involved in providing patient care and who wish to advance their current knowledge of clinical medicine. This CME Conference has been approved for a maximum of 0.75 AMA PRA Category 1 Credits.

Conference Objectives are :
Upon completion of the article by Nash et al, the participant should be able to:
• State the incidence of adverse events observed during this study in patients treated with high-dose immunosuppressive therapy and hematopoietic cell transplantation.
• Estimate the proportion of patients experiencing event-free survival following treatment in this study.
• Discuss changes in neurologic disability (as measured by the Expanded Disability Status Scale) observed following treatment in this study.

Additional details will be posted as soon as they are available.

Target Audience

Hematology Blood and Marrow Transplant, Immunotherapies, Hematopathology


Activity Fee : Fee Details will be updated soon


Hematology Blood and Marrow Transplant, Immunotherapies, Hematopathology

Onsite to Virtual Conference

Market your online event to Million plus Healthcare professionals.